Table 1 Significantly enriched miRNA seed variants in the comparison of patient cohort with gnomAD NFE population.

From: Analysis of DNA variants in miRNAs and miRNA 3ʼUTR binding sites in female infertility patients

miRNA

Chr

Start

End

Ref

Alt

dbSNP150

AF_Patienta

AF_gnomAD NFEa

pValb

FDRc

hsa-mir-4472-2-5p

12

116866112

116866114

CA

rs202127912

0.23

1.60E−02

2.6E−54

1.5E−51

hsa-mir-8078-3p

18

112284

112285

G

C

0

0.17

3.90E−02

2.2E−16

6.1E−15

hsa-mir-8078-3p

18

112286

112287

C

A

rs775697263

0.15

3.50E−02

4.3E−16

1.2E−14

hsa-mir-8078-3p

18

112281

112282

C

A

0

0.04

1.00E−03

5.4E−13

1.2E−11

hsa-mir-1273a-3p

8

101036233

101036234

G

A

rs932668866

0.01

1.34E−04

1.2E−04

1.5E−03

hsa-mir-6859-1-3p

1

17384

17385

G

A

rs201535981

0.25

1.60E−01

6.1E−04

6.8E−03

hsa-mir-1273d-5p

1

10287790

10287791

A

G

0

0.01

6.74E−05

1.6E−03

1.6E−02

hsa-mir-302c-3p

4

113569539

113569543

ACTT

rs199971565

0.06

3.00E−02

5.1E−03

4.4E−02

  1. aAllele frequency of the patient and gnomAD NFE group, respectively.
  2. bRaw p value from Fisher’s Exact test.
  3. cBenjamini–Hochberg adjusted p value.